Show simple item record

dc.contributor.authorBihrer, Verena
dc.contributor.authorFriedrich-Rust, Mireen
dc.contributor.authorKronenberger, Bernd
dc.contributor.authorForestier, Nicole
dc.contributor.authorHaupenthal, Jörg
dc.contributor.authorShi, Ying
dc.contributor.authorPeveling-Oberhag, Jan
dc.contributor.authorRadeke, Heinfried H
dc.contributor.authorSarrazin, Christoph
dc.contributor.authorHerrmann, Eva
dc.contributor.authorZeuzem, Stefan
dc.contributor.authorWaidmann, Oliver
dc.contributor.authorPiiper, Albrecht
dc.date.accessioned2012-03-05T14:52:18Z
dc.date.available2012-03-05T14:52:18Z
dc.date.issued2011-09
dc.identifier.citationSerum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. 2011, 106 (9):1663-9 Am. J. Gastroenterol.en
dc.identifier.issn1572-0241
dc.identifier.pmid21606975
dc.identifier.doi10.1038/ajg.2011.161
dc.identifier.urihttp://hdl.handle.net/10033/214238
dc.description.abstractThe liver contains large amounts of microRNA-122 (miR-122), whereas other tissues contain only marginal amounts of this miRNA. MicroRNAs have also been found to circulate in the blood in a cell-free form; their potential as readily accessible disease markers is currently evaluated. Here, we investigated if the serum levels of miR-122 might be useful as disease parameter in patients with chronic hepatitis C virus (HCV) infection.
dc.language.isoenen
dc.subject.meshAdulten
dc.subject.meshAgeden
dc.subject.meshAlanine Transaminaseen
dc.subject.meshAspartate Aminotransferasesen
dc.subject.meshBilirubinen
dc.subject.meshBiological Markersen
dc.subject.meshFemaleen
dc.subject.meshHepatitis C, Chronicen
dc.subject.meshHumansen
dc.subject.meshInternational Normalized Ratioen
dc.subject.meshLiveren
dc.subject.meshMaleen
dc.subject.meshMicroRNAsen
dc.subject.meshMiddle Ageden
dc.subject.meshNecrosisen
dc.subject.meshSerum Albuminen
dc.titleSerum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medicine I, University of Frankfurt/M., Frankfurt, Germany.en
dc.identifier.journalThe American journal of gastroenterologyen
refterms.dateFOA2012-03-15T00:00:00Z
html.description.abstractThe liver contains large amounts of microRNA-122 (miR-122), whereas other tissues contain only marginal amounts of this miRNA. MicroRNAs have also been found to circulate in the blood in a cell-free form; their potential as readily accessible disease markers is currently evaluated. Here, we investigated if the serum levels of miR-122 might be useful as disease parameter in patients with chronic hepatitis C virus (HCV) infection.


Files in this item

Thumbnail
Name:
Bihrer et al_final.pdf
Size:
1.671Mb
Format:
PDF
Description:
original manuscript

This item appears in the following Collection(s)

Show simple item record